Status:
WITHDRAWN
Hexoskin Feasibility Study With COVID-19 Patients
Lead Sponsor:
Nguyen Thu Ngan Trinh
Conditions:
COVID-19
Eligibility:
All Genders
55+ years
Brief Summary
This pilot study aims to investigate the feasibility of using Hexoskin cardiorespiratory and activity data, as well as patient symptomatology, to provide an AI model for disease progression that will ...
Detailed Description
The following protocol proposes a mixed methods pilot study, whereby the immediate purpose is to generate quantifiable information regarding the feasibility of a virtual trial with the Hexoskin Platfo...
Eligibility Criteria
Inclusion
- Minimum waist size of 24 inches, and maximum waist size of 45 inches
- Confirmed COVID-19 diagnosis from a licensed healthcare practitioner
- Permanent resident or citizen of the United States
- Access to a smartphone
- Access to a functional email
- Access to a thermometer
- Access to a measuring tape
- Experiencing at least three of the following COVID-19 symptoms (fever, cough, difficulty breathing, intense fatigue, sudden loss of smell and/or taste without nasal congestion, sore throat, headache, aching muscles, loss of appetite, diarrhea).
Exclusion
- Hexoskin should not be used by people with allergies to the following materials: polyester, synthetic fibers. Usage must be stopped if the product causes skin irritation or rashes.
- Hexoskin should not be used by people with Pacemakers or Implantable Cardioverter-Defibrillator (ICD) devices.
- Hexoskin must not be used simultaneously with a Holter Monitor, as the equipment would interfere with the placement of the Hexoskin sensors.
- Hexoskin must not be used in an MRI machine as it contains metallic parts.
- Individuals who do not fit any of the Hexoskin Shirts sizes (Men: between 2XS - 6XL, Women: between 2XS - 4XL).
- Individuals who have a documented medical condition or illness requiring intensive medical treatment.
- Women of Childbearing Potential whom are not using effective contraceptive measures
Key Trial Info
Start Date :
July 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 9 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04453891
Start Date
July 15 2022
End Date
August 9 2022
Last Update
August 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.